Targeted Medical Pharma, Inc.
TRGM
$0.00
$0.000.00%
| 12/31/2015 | 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | |
|---|---|---|---|---|---|
| Revenue | 5.26M | 5.39M | 5.50M | 6.38M | 7.11M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.26M | 5.39M | 5.50M | 6.38M | 7.11M |
| Cost of Revenue | 2.10M | 2.23M | 2.23M | 2.21M | 2.22M |
| Gross Profit | 3.17M | 3.15M | 3.27M | 4.17M | 4.90M |
| SG&A Expenses | 5.04M | 5.77M | 6.50M | 7.10M | 7.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.15M | 8.03M | 8.81M | 9.41M | 9.72M |
| Operating Income | -1.89M | -2.64M | -3.31M | -3.04M | -2.61M |
| Income Before Tax | -3.07M | -3.95M | -4.72M | -4.53M | -3.83M |
| Income Tax Expenses | -- | 0.00 | 0.00 | 65.80K | 65.80K |
| Earnings from Continuing Operations | -3.07 | -3.95 | -4.72 | -4.60 | -3.90 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 23.40K | -- | -- | -- | -- |
| Net Income | -3.04M | -3.95M | -4.72M | -4.60M | -3.90M |
| EBIT | -1.89M | -2.64M | -3.31M | -3.04M | -2.61M |
| EBITDA | -1.66M | -2.36M | -2.99M | -2.67M | -2.21M |
| EPS Basic | -0.11 | -0.15 | -0.18 | -0.17 | -0.15 |
| Normalized Basic EPS | -0.07 | -0.09 | -0.11 | -0.10 | -0.09 |
| EPS Diluted | -0.11 | -0.15 | -0.18 | -0.17 | -0.15 |
| Normalized Diluted EPS | -0.07 | -0.09 | -0.11 | -0.10 | -0.09 |
| Average Basic Shares Outstanding | 108.86M | 107.84M | 106.93M | 106.40M | 105.54M |
| Average Diluted Shares Outstanding | 108.86M | 107.84M | 106.93M | 106.40M | 105.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
